In the U.S., dialysis is a costly treatment with poor health outcomes. According to the Centers for Disease Control and Prevention, 15% of adults—37 million people—have chronic kidney disease. As the disease progresses ...
Nov 10, 2022
0
15
Serious kidney-related complications—or major adverse kidney events—are common after hospitalization for various medical problems. Investigators have now developed and validated an artificial intelligence-based algorithm ...
Nov 3, 2022
0
5
In a study published in CJASN that included older adults with advanced chronic kidney disease, mental and physical health-related quality of life (HRQoL) worsened in the year before patients started dialysis, but this decline ...
Jul 28, 2022
0
51
For patients with moderate- to end-stage chronic kidney disease, elobixibat is associated with improvement in constipation and lipid metabolism, according to a study recently published in Frontiers in Medicine.
Mar 21, 2022
0
12
(HealthDay)—For patients with high blood pressure (BP) and chronic kidney disease (CKD) who are not receiving dialysis, a systolic BP of under 120 mm Hg measured by standardized technique should be targeted, according to ...
Jun 22, 2021
0
5
It's widely known that the causative agent for COVID-19, the SARS-CoV-2 virus, can spread rapidly among residents in nursing homes and other long-term care facilities, leading to high numbers of cases and deaths in a very ...
Aug 25, 2020
0
2
Chronic kidney disease (CKD) affects 14 percent of adults in the U.S. There are several stages of CKD, but when it progresses to kidney failure, outcomes are quite poor, with those patients dying at a higher rate than patients ...
Feb 13, 2020
0
38
Fewer women than men receive kidney replacement therapy, such as dialysis or kidney transplantation, and a recent analysis from Europe reveals that this difference has remained consistent over the last 5 decades and across ...
Oct 24, 2019
0
0
In patients with advanced chronic kidney disease (CKD), receiving high intensity care before death was linked with lower family satisfaction with care, while receiving palliative and hospice care was associated with greater ...
Aug 29, 2019
0
0
FibroGen, Inc. today announced publication of results from the Phase 3 trial of the efficacy and safety of roxadustat treatment compared to placebo for anemia in non-dialysis patients (NDD) with chronic kidney disease (CKD) ...
Jul 25, 2019
0
2
